Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15618744rdf:typepubmed:Citationlld:pubmed
pubmed-article:15618744lifeskim:mentionsumls-concept:C0037269lld:lifeskim
pubmed-article:15618744lifeskim:mentionsumls-concept:C0026056lld:lifeskim
pubmed-article:15618744lifeskim:mentionsumls-concept:C0039561lld:lifeskim
pubmed-article:15618744lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:15618744pubmed:issue4lld:pubmed
pubmed-article:15618744pubmed:dateCreated2004-12-27lld:pubmed
pubmed-article:15618744pubmed:abstractTextMidazolam is a highly lipophilic drug that is widely used in preanesthetic medication. Recently, terpenes have been reported to show an enhancing effect on percutaneous absorption of drugs. The effect of terpenes (l-menthol, d-limonene, RS-(+/-)-beta-citronellol, geraniol) on the in vitro percutaneous absorption of midazolam through rat skin was evaluated using unjacketed Franz diffusion cells. Since midazolam is a lipophilic drug, percutaneous penetration is low and a percutaneous penetration enhancer is necessary for its percutaneous absorption. The terpenes (5%, w/v) in combination with 30% ethanol, and 20% propylene glycol significantly increased the percutaneous absorption of midazolam in comparison to the control. In vitro data suggested that d-limonene is the most effective enhancer among terpenes and other penetration enhancers such as Azone. In in vivo percutaneous absorption assays, the midazolam formulation using d-limonene could penetrate through rat skin, but the other terpenes could not penetrate. In conclusion, d-limonene in combination with ethanol can be used to enhance the percutaneous absorption of the highly lipophilic drug midazolam.lld:pubmed
pubmed-article:15618744pubmed:languageenglld:pubmed
pubmed-article:15618744pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618744pubmed:statusPubMed-not-MEDLINElld:pubmed
pubmed-article:15618744pubmed:issn1347-4367lld:pubmed
pubmed-article:15618744pubmed:authorpubmed-author:SaitoHideyuki...lld:pubmed
pubmed-article:15618744pubmed:authorpubmed-author:HamadaAkinobu...lld:pubmed
pubmed-article:15618744pubmed:authorpubmed-author:NakanoMasahir...lld:pubmed
pubmed-article:15618744pubmed:authorpubmed-author:OtaYusukeYlld:pubmed
pubmed-article:15618744pubmed:issnTypePrintlld:pubmed
pubmed-article:15618744pubmed:volume18lld:pubmed
pubmed-article:15618744pubmed:ownerNLMlld:pubmed
pubmed-article:15618744pubmed:authorsCompleteYlld:pubmed
pubmed-article:15618744pubmed:pagination261-6lld:pubmed
pubmed-article:15618744pubmed:year2003lld:pubmed
pubmed-article:15618744pubmed:articleTitleEvaluation of percutaneous absorption of midazolam by terpenes.lld:pubmed
pubmed-article:15618744pubmed:affiliationDepartment of Pharmacy, Kumamoto University Hospital, Japan.lld:pubmed
pubmed-article:15618744pubmed:publicationTypeJournal Articlelld:pubmed